IS5070A - Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það - Google Patents

Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það

Info

Publication number: IS5070A
Authority: IS; Iceland
Prior art keywords: omeprazole; enantiomer; pharmaceutical preparation; preparation containing; new form
Prior art date: 1996-12-20

Application number

IS5070A

Other languages

English (en)

Other versions

IS1981B (is

Inventor

Bohlin Martin

Horvath Karol

Von Unge Sverker

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-20

Filing date

1999-06-07

Publication date

1999-06-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20405146&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5070(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-06-07 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

1999-06-07 Publication of IS5070A publication Critical patent/IS5070A/is

2005-01-14 Publication of IS1981B publication Critical patent/IS1981B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IS5070A 1996-12-20 1999-06-07 Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það IS1981B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9604793A SE510666C2 (sv)	1996-12-20	1996-12-20	Nya Kristallmodifikationer
PCT/SE1997/002125 WO1998028294A1 (en)	1996-12-20	1997-12-16	A novel compound form

Publications (2)

Publication Number	Publication Date
IS5070A true IS5070A (is)	1999-06-07
IS1981B IS1981B (is)	2005-01-14

Family

ID=20405146

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5070A IS1981B (is)	1996-12-20	1999-06-07	Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það

Country Status (36)

Country	Link
US (1)	US6162816A (is)
EP (1)	EP0946547B1 (is)
JP (1)	JP4402174B2 (is)
KR (1)	KR20000069595A (is)
CN (1)	CN1109684C (is)
AR (1)	AR010361A1 (is)
AT (1)	ATE236898T1 (is)
AU (1)	AU730129B2 (is)
BR (1)	BR9714059A (is)
CA (1)	CA2274076C (is)
CZ (1)	CZ294784B6 (is)
DE (1)	DE69720774T2 (is)
DK (1)	DK0946547T3 (is)
EE (1)	EE03923B1 (is)
EG (1)	EG24414A (is)
ES (1)	ES2194231T3 (is)
HU (1)	HU227589B1 (is)
ID (1)	ID21850A (is)
IL (1)	IL130450A0 (is)
IS (1)	IS1981B (is)
MY (1)	MY117032A (is)
NO (1)	NO317191B1 (is)
NZ (1)	NZ336024A (is)
PL (1)	PL190377B1 (is)
PT (1)	PT946547E (is)
RS (1)	RS49685B (is)
RU (1)	RU2184734C2 (is)
SA (1)	SA97180739B1 (is)
SE (1)	SE510666C2 (is)
SI (1)	SI0946547T1 (is)
SK (1)	SK285151B6 (is)
TR (1)	TR199901410T2 (is)
TW (1)	TW538039B (is)
UA (1)	UA55436C2 (is)
WO (1)	WO1998028294A1 (is)
ZA (1)	ZA9711046B (is)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6699885B2 (en)	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en)	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
SI20019A (sl) *	1998-07-13	2000-02-29	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
UA72748C2 (en) *	1998-11-10	2005-04-15	Astrazeneca Ab	A novel crystalline form of omeprazole
IL142703A (en)	1998-11-10	2006-04-10	Astrazeneca Ab	Crystalline form of omeprazole
JP3926936B2 (ja) *	1998-11-16	2007-06-06	エーザイ・アール・アンド・ディー・マネジメント株式会社	スルホキシド誘導体・アセトン錯体およびその製造法
SE9804003D0 (sv)	1998-11-23	1998-11-23	Astra Ab	A method of producing drug particles
SE9900274D0 (sv)	1999-01-28	1999-01-28	Astra Ab	New compound
JP2000344739A (ja) *	1999-06-01	2000-12-12	Sumitomo Chem Co Ltd	Ｎ−保護−アゼチジン−２−カルボン酸の製造方法
TWI275587B (en)	1999-06-17	2007-03-11	Takeda Chemical Industries Ltd	A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
SE0000773D0 (sv) *	2000-03-08	2000-03-08	Astrazeneca Ab	New formulation
SE0000774D0 (sv) *	2000-03-08	2000-03-08	Astrazeneca Ab	New formulation
WO2001087874A1 (en)	2000-05-15	2001-11-22	Takeda Chemical Industries, Ltd.	Process for producing crystal
GB0016040D0 (en) *	2000-06-29	2000-08-23	Glaxo Group Ltd	Novel process for preparing crystalline particles
EP1306375B1 (en)	2000-08-04	2006-10-11	Takeda Pharmaceutical Company Limited	Salts of benzimidazole compound and application thereof
SI20875A (sl) *	2001-04-25	2002-10-31	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Kristalna oblika omeprazola
ATE474559T1 (de)	2001-06-01	2010-08-15	Pozen Inc	Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid
US8206741B2 (en)	2001-06-01	2012-06-26	Pozen Inc.	Pharmaceutical compositions for the coordinated delivery of NSAIDs
GB2376231A (en)	2001-06-06	2002-12-11	Cipla Ltd	Benzimidazole-cyclodextrin inclusion complex
SE0102993D0 (sv)	2001-09-07	2001-09-07	Astrazeneca Ab	New self emulsifying drug delivery system
WO2004002982A2 (en) *	2002-06-27	2004-01-08	Dr. Reddy's Laboratories Limited	A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
AU2003247729B2 (en) *	2002-06-27	2009-10-08	Dr. Reddy's Laboratories Limited	A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
CA2501424A1 (en) *	2002-08-30	2004-03-11	Dr. Reddy's Laboratories Limited	Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
EP1552833B1 (en)	2002-10-16	2016-12-28	Takeda Pharmaceutical Company Limited	Process for producing an amorphous optically active isomer of lansoprazole
BR0315574A (pt) *	2002-10-22	2005-09-20	Ranbaxy Lab Ltd	Forma amorfa de esomeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação
WO2004046134A2 (en) *	2002-11-18	2004-06-03	Dr. Reddy's Laboratories Limited	Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
MXPA05009183A (es) *	2003-02-28	2005-10-20	Ranbaxy Lab Ltd	Polimorfos de s-omeprazol.
JP4787017B2 (ja) *	2003-03-24	2011-10-05	エーザイ・アール・アンド・ディー・マネジメント株式会社	スルホキシド誘導体またはその塩のアモルファスの製造方法
EP1633736A1 (en) *	2003-05-05	2006-03-15	Ranbaxy Laboratories Limited	Barium salt of benzimidazole derivative
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0400410D0 (sv)	2004-02-20	2004-02-20	Astrazeneca Ab	New compounds
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en)	2004-05-25	2014-08-26	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1768668A2 (en)	2004-06-16	2007-04-04	Tap Pharmaceutical Products, Inc.	Multiple ppi dosage form
CN1972928A (zh)	2004-06-24	2007-05-30	阿斯利康(瑞典)有限公司	制备用于制备依美拉唑钠盐的结晶修饰物的新方法
ES2246149B1 (es) *	2004-07-02	2007-06-01	Esteve Quimica, S.A.	Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
US20090298884A1 (en) *	2005-05-06	2009-12-03	Glenmark Generics Ltd.	Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same
WO2006131338A2 (en) *	2005-06-08	2006-12-14	Lek Pharmaceuticals D.D.	Crystalline solvate of omeprazole sodium
EP1891043A1 (en)	2005-06-15	2008-02-27	Hetero Drugs Limited	Amorphous esomeprazole hydrate
NL2000126C2 (nl) *	2005-07-15	2008-01-29	Solvay	Werkwijze voor de vervaardiging van eptifibatide.
US20070043085A1 (en) *	2005-08-19	2007-02-22	Glenmark Pharmaceuticals Limited	Process for the preparation of amorphous form of neutral esomeprazole
US7576219B2 (en)	2005-10-26	2009-08-18	Hanmi Pharm. Co., Ltd	Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
WO2007054951A1 (en) *	2005-11-14	2007-05-18	Hetero Drugs Limited	Process for amorphous esomeprazole
BRPI0619158A2 (pt) *	2005-12-05	2011-09-20	Astrazeneca Ab	processo para preparar forma que não que não seja sal de esomeprazol, composto, formulação farmacêutica, e, método de tratamento
EP1801110A1 (en)	2005-12-22	2007-06-27	KRKA, tovarna zdravil, d.d., Novo mesto	Esomeprazole arginine salt
ATE428707T1 (de)	2005-12-28	2009-05-15	Union Quimico Farma	Verfahren zur herstellung des (s)-enantiomers von omeprazol
EP2000468A1 (en) *	2007-05-09	2008-12-10	Dr. Reddy's Laboratories Ltd.	Esomeprazole salts and processes for preparation thereof
US8106210B2 (en)	2007-10-08	2012-01-31	Hetero Drugs Limited	Polymorphs of esomeprazole salts
AR070972A1 (es)	2008-03-10	2010-05-19	Takeda Pharmaceutical	Cristal de compuestos de bencimidazol (lansoprazol)
EP2143722A1 (en)	2008-07-09	2010-01-13	Lek Pharmaceuticals D.D.	Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
CN102209529A (zh) *	2008-09-09	2011-10-05	阿斯利康(瑞典)有限公司	将药物组合物递送至有需要的患者的方法
CN102481293A (zh)	2009-06-25	2012-05-30	阿斯利康(瑞典)有限公司	治疗具有发展nsaid-相关的溃疡的风险的患者的方法
CN102884178B (zh)	2009-12-08	2014-12-03	科德克希思公司	拉唑化合物的合成
EP2649187B1 (en)	2010-12-08	2017-11-22	Codexis, Inc.	Biocatalysts and methods for the synthesis of armodafinil
WO2013101897A2 (en)	2011-12-28	2013-07-04	Pozen Inc.	Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
RU2501549C1 (ru)	2012-08-30	2013-12-20	Авва Девелопмент Лтд	Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни
CN107043367A (zh) *	2017-05-26	2017-08-15	重庆莱美隆宇药业有限公司	一种中性s‑奥美拉唑的干燥工艺
JP2025532389A (ja)	2022-10-04	2025-09-29	ザビリュク，アルセニー	大動脈弁の石灰化の抑制

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv) *	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
SE8301182D0 (sv) *	1983-03-04	1983-03-04	Haessle Ab	Novel compounds
GB2189698A (en) *	1986-04-30	1987-11-04	Haessle Ab	Coated omeprazole tablets
SE9002043D0 (sv) *	1990-06-07	1990-06-07	Astra Ab	Improved method for synthesis
DE4035455A1 (de) *	1990-11-08	1992-05-14	Byk Gulden Lomberg Chem Fab	Enantiomerentrennung
US5877192A (en) *	1993-05-28	1999-03-02	Astra Aktiebolag	Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
SE9301830D0 (sv) *	1993-05-28	1993-05-28	Ab Astra	New compounds
SE9302396D0 (sv) *	1993-07-09	1993-07-09	Ab Astra	A novel compound form
CZ289804B6 (cs) *	1994-07-08	2002-04-17	Astrazeneca Ab	Multijednotková tabletovaná dávková forma I

1996
- 1996-12-20 SE SE9604793A patent/SE510666C2/sv unknown
1997
- 1997-12-08 TW TW086118449A patent/TW538039B/zh not_active IP Right Cessation
- 1997-12-09 ZA ZA9711046A patent/ZA9711046B/xx unknown
- 1997-12-16 CA CA002274076A patent/CA2274076C/en not_active Expired - Fee Related
- 1997-12-16 KR KR1019997005574A patent/KR20000069595A/ko not_active Ceased
- 1997-12-16 EP EP97951367A patent/EP0946547B1/en not_active Expired - Lifetime
- 1997-12-16 PT PT97951367T patent/PT946547E/pt unknown
- 1997-12-16 JP JP52868598A patent/JP4402174B2/ja not_active Expired - Fee Related
- 1997-12-16 TR TR1999/01410T patent/TR199901410T2/xx unknown
- 1997-12-16 RU RU99116303/04A patent/RU2184734C2/ru not_active IP Right Cessation
- 1997-12-16 RS YUP-281/99A patent/RS49685B/sr unknown
- 1997-12-16 CZ CZ19992202A patent/CZ294784B6/cs not_active IP Right Cessation
- 1997-12-16 ES ES97951367T patent/ES2194231T3/es not_active Expired - Lifetime
- 1997-12-16 SI SI9730528T patent/SI0946547T1/xx unknown
- 1997-12-16 DK DK97951367T patent/DK0946547T3/da active
- 1997-12-16 DE DE69720774T patent/DE69720774T2/de not_active Expired - Lifetime
- 1997-12-16 AU AU55026/98A patent/AU730129B2/en not_active Ceased
- 1997-12-16 EE EEP199900259A patent/EE03923B1/xx not_active IP Right Cessation
- 1997-12-16 AR ARP970105920A patent/AR010361A1/es active IP Right Grant
- 1997-12-16 NZ NZ336024A patent/NZ336024A/en not_active IP Right Cessation
- 1997-12-16 AT AT97951367T patent/ATE236898T1/de active
- 1997-12-16 UA UA99073869A patent/UA55436C2/uk unknown
- 1997-12-16 HU HU0001547A patent/HU227589B1/hu not_active IP Right Cessation
- 1997-12-16 US US09/000,154 patent/US6162816A/en not_active Expired - Lifetime
- 1997-12-16 BR BR9714059-7A patent/BR9714059A/pt not_active Application Discontinuation
- 1997-12-16 WO PCT/SE1997/002125 patent/WO1998028294A1/en not_active Ceased
- 1997-12-16 SK SK765-99A patent/SK285151B6/sk not_active IP Right Cessation
- 1997-12-16 IL IL13045097A patent/IL130450A0/xx not_active IP Right Cessation
- 1997-12-16 PL PL97334297A patent/PL190377B1/pl not_active IP Right Cessation
- 1997-12-16 CN CN97180849A patent/CN1109684C/zh not_active Expired - Fee Related
- 1997-12-16 ID IDW990483A patent/ID21850A/id unknown
- 1997-12-19 MY MYPI97006176A patent/MY117032A/en unknown
- 1997-12-20 EG EG136097A patent/EG24414A/xx active
- 1997-12-27 SA SA97180739A patent/SA97180739B1/ar unknown
1999
- 1999-06-07 IS IS5070A patent/IS1981B/is unknown
- 1999-06-21 NO NO19993068A patent/NO317191B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
TR199901410T2 (xx)	1999-08-23
PT946547E (pt)	2003-07-31
NZ336024A (en)	2001-02-23
KR20000069595A (ko)	2000-11-25
NO993068D0 (no)	1999-06-21
SE9604793L (sv)	1998-06-21
IS1981B (is)	2005-01-14
ES2194231T3 (es)	2003-11-16
HU227589B1 (en)	2011-09-28
HUP0001547A3 (en)	2002-06-28
TW538039B (en)	2003-06-21
SE9604793D0 (sv)	1996-12-20
NO317191B1 (no)	2004-09-13
MY117032A (en)	2004-04-30
EP0946547B1 (en)	2003-04-09
AU730129B2 (en)	2001-02-22
RU2184734C2 (ru)	2002-07-10
HK1022909A1 (en)	2000-08-25
IL130450A0 (en)	2000-06-01
PL190377B1 (pl)	2005-12-30
BR9714059A (pt)	2000-05-09
PL334297A1 (en)	2000-02-14
SK285151B6 (sk)	2006-07-07
AR010361A1 (es)	2000-06-07
EE9900259A (et)	2000-02-15
CN1241183A (zh)	2000-01-12
EP0946547A1 (en)	1999-10-06
US6162816A (en)	2000-12-19
DK0946547T3 (da)	2003-06-30
CA2274076C (en)	2008-09-30
ZA9711046B (en)	1998-06-22
SI0946547T1 (en)	2003-10-31
YU28199A (sh)	2002-03-18
SA97180739B1 (ar)	2006-05-20
SK76599A3 (en)	1999-12-10
ID21850A (id)	1999-08-05
CA2274076A1 (en)	1998-07-02
UA55436C2 (uk)	2003-04-15
AU5502698A (en)	1998-07-17
CZ220299A3 (cs)	2000-02-16
DE69720774T2 (de)	2004-02-05
ATE236898T1 (de)	2003-04-15
NO993068L (no)	1999-06-21
HUP0001547A2 (hu)	2002-05-29
CZ294784B6 (cs)	2005-03-16
RS49685B (sr)	2007-11-15
JP4402174B2 (ja)	2010-01-20
EG24414A (en)	2009-05-25
WO1998028294A1 (en)	1998-07-02
DE69720774D1 (de)	2003-05-15
EE03923B1 (et)	2002-12-16
JP2001507025A (ja)	2001-05-29
SE510666C2 (sv)	1999-06-14
CN1109684C (zh)	2003-05-28
HU0001547D0 (is)	2002-05-29

Publication	Publication Date	Title
IS5070A (is)	1999-06-07	Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það
IS5245A (is)	1999-11-11	Lyfjablanda úr ómeprasól
NO984107D0 (no)	1998-09-07	Kappa agnostiske forbindelser og farmasöytiske ormuleringer derav
NO20000932D0 (no)	2000-02-25	Farmasøytisk preparat for kombinasjon av piperidinoalkanol og dekongestant
ID19343A (id)	1998-07-02	Alat penghirup bubuk obat
DE69513671D1 (de)	2000-01-05	Arzneimittel
NO307707B1 (no)	2000-05-15	Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
FI964682L (fi)	1997-01-20	Glukagonia sisältävä farmaseuttinen valmiste
DE69737936D1 (de)	2007-08-30	Arzneimittel
NO20021401D0 (no)	2002-03-20	Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
DK0994706T3 (da)	2006-03-06	Præparater til oral indgivelse af taxaner og anvendelse deraf
NO20006576L (no)	2001-02-14	Et substituert triazol-pyridazinderivat og farmasöytiske preparater fremstilt av dette
CZ2000522A3 (cs)	2000-09-13	Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití
BR9509688A (pt)	1997-09-30	Composto e composição farmacêutica
NO20001717D0 (no)	2000-04-03	Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
NO990520L (no)	1999-03-24	FremgangsmÕte for fremstilling av cykliske depsipeptidforbindelser og et nytt cyklisk depsipeptid
ITMI941169A0 (it)	1994-06-06	Formulazioni farmaceutiche
IT1289883B1 (it)	1998-10-19	Composizione farmaceutica antitubercolare e procedimento per la sua produzione
EE9800275A (et)	1999-02-15	Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
FI951155A7 (fi)	1995-09-15	Farmaseuttinen valmiste
FI961364L (fi)	1997-09-26	Lääkeainekoostumus
BR9505130A (pt)	1997-09-09	Composto e composiçao farmacêutica
SE9703737D0 (sv)	1997-10-14	Pharmaceutical composition and use
SK1380U (sk)	1997-02-05	Farmaceutický preparát
SE9404467D0 (sv)	1994-12-22	Drug formulations